Image

A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD

Join a study testing new COPD treatments with Ensifentrine-glycopyrrolate.

Recruiting
40-80 years
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)
This study examines a new combination of medicines for people with COPD (Chronic Obstructive Pulmonary Disease), a lung disease that makes it hard to breathe. Participants will try two different fixed-dose combinations of ensifentrine and glycopyrrolate, both of which help open airways. They will also compare these to placebo (a treatment with no active medicine) and the individual medicines. All treatments are inhaled using a nebulizer, a machine that turns liquid medicine into a mist. Key Points:
  • The study lasts about 7 weeks, including screening, treatment, and follow-up.
  • Participants must agree to use birth control and be non-smokers or have quit for at least 6 months.
  • Participants should not have other major lung diseases or severe health issues.
Eligibility: Adults with a history of COPD, smokers with a history of at least 10 pack years, and the ability to correctly use the nebulizer are eligible. Participants must attend all appointments and follow study instructions. They should not have major health issues like heart problems or drug abuse history.
Print
Study details
    Chronic Obstructive Pulmonary Disease

NCT07016412

Verona Pharma plc

7 March 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.